drugset / Trial / NCT02066727
Lidocaine Combined Dexmedetomidine for Obturator Nerve Block
RandomizedParallel-groupDouble-blindTreatment
Summary
Hypothesis: Dexmedetomidine as an adjuvant of lidocaine can decrease the median effective concentration(EC50) of lidocaine for obturator nerve block during transurethral resection of bladder tumor
Timeline
- Start
- 2014-02
- Primary completion
- 2014-04
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 1 ug/kg | Other |